|
|
Volumn 275, Issue 5299, 1997, Pages 482-484
|
|
Designing therapies that target tumor blood vessels
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
CALCIUM CHANNEL BLOCKING AGENT;
ENTREMED;
FUMAGILLOL CHLOROACETYLCARBAMATE;
INTEGRIN;
INTERLEUKIN 12;
MARIMASTAT;
METALLOPROTEINASE INHIBITOR;
THALIDOMIDE;
THROMBOCYTE FACTOR 4;
THROMBOSPONDIN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
CANCER INHIBITION;
CANCER THERAPY;
CLINICAL TRIAL;
HUMAN;
NOTE;
PRIORITY JOURNAL;
TUMOR VASCULARIZATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BLOOD COAGULATION;
CLINICAL TRIALS;
ENDOTHELIUM, VASCULAR;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
THROMBOPLASTIN;
|
|
EID: 0031017133
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.275.5299.482 Document Type: Note |
|
Times cited : (70)
|
|
References (0)
|